Benitec Biopharma (BNTC) Retained Earnings: 2019-2025
Historic Retained Earnings for Benitec Biopharma (BNTC) over the last 5 years, with Mar 2025 value amounting to -$219.4 million.
- Benitec Biopharma's Retained Earnings fell 18.63% to -$219.4 million in Q1 2025 from the same period last year, while for Mar 2025 it was -$219.4 million, marking a year-over-year decrease of 18.63%. This contributed to the annual value of -$190.3 million for FY2024, which is 13.32% down from last year.
- Benitec Biopharma's Retained Earnings amounted to -$219.4 million in Q1 2025, which was down 7.08% from -$204.9 million recorded in Q4 2024.
- In the past 5 years, Benitec Biopharma's Retained Earnings ranged from a high of -$126.1 million in Q1 2021 and a low of -$219.4 million during Q1 2025.
- Over the past 3 years, Benitec Biopharma's median Retained Earnings value was -$184.9 million (recorded in 2024), while the average stood at -$186.7 million.
- Data for Benitec Biopharma's Retained Earnings shows a maximum YoY dropped of 18.63% (in 2025) over the last 5 years.
- Benitec Biopharma's Retained Earnings (Quarterly) stood at -$140.0 million in 2021, then dropped by 13.46% to -$158.8 million in 2022, then dropped by 13.73% to -$180.6 million in 2023, then declined by 13.41% to -$204.9 million in 2024, then decreased by 18.63% to -$219.4 million in 2025.
- Its Retained Earnings was -$219.4 million in Q1 2025, compared to -$204.9 million in Q4 2024 and -$195.3 million in Q3 2024.